SCIENTIFIC POSTERS

 

Join us every lunch from April 10-12 to see our handpicked posters that are demonstrating some of the most cutting edge research. 

Our posters include:

Poster #1

Serum Antibody response and Dengue virus cross-reactivity profiling after Zika virus infection in rhesus macaques.
John C. Tan1, Emma L. Mohr3, Adam Bailey2, Adam Ericson2, Connor Buechler2, Dawn M. Dudley2, Christina Newman2, Mariel S. Mohns2, Meghan E. Breitbach2, Laurel Stewart2, Sarah J. Barilovits1, Jigar Patel1, David H. O’Connor2
Affiliations: 1Roche Sequencing Solutions, Inc., 2Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, 3Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison

Poster #2

Serum and Antibody Profiling Applications of Roche Innovation Madison High-Density Peptide Arrays
Brad Garcia1, Ken Lo1, John C. Tan1, Eric Sullivan1, Ryan Bannen1, Klaus-Peter Stengele2, Thomas Albert1, Jigar Patel1
Affiliations: 1Department of Innovation, Roche Sequencing Solutions – Madison, 500 S. Rosa Road, Madison WI 53719, USA; 2Roche Diagnostics, Nonnenwald 2, Penzberg, Germany

Poster #3

Intranasal Delivery of VitriLife® Live-Attenuated Influenza Vaccine Powder Elicits Robust and Protective Immune Responses in Ferrets.
Victor Bronshtein, Ph.D.; S. Mark Tompkins, Ph.D.; Tatiana Bousse, Ph.D.; Min-Xuan Wang, B.Sc.; Erin A. Miller, B.Sc.; Edward Vonsovich, M.D.; Scott K. Johnson, M.S.; Cheryl A. Jones, B.Sc.; Jasmina M. Luczo, Ph.D.; David E. Wentworth, Ph.D.; Nikolai Petrovsky, M.D.; Mark Papania, M.D. MPH

Universal Stabilization Technologies, Inc., San Diego, CA 92121
Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602
Center for Disease Control and Prevention, Atlanta, GA 30333
Vaxine Pty Ltd, Bedford Park, Adelaide, Australia 5042

Poster #4

Development of a third generation of Her-2/neu multipeptide vaccine including Trastuzumab and Pertuzumab binding site mimotopes.
Authors:
Joshua Tobias1, Karin Baier, Katharina Ambroz, Dejana Dejanovic1, Christoph C. Zielinski2, Ursula Wiedermann
Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Immunology & Infectiology, Medical University of Vienna, Vienna, Austria
Division of Oncology, Department of Medicine I, Medical University of Vienna, General Hospital, Vienna, Austria

Poster #5

MDCK Proliferation and Flu Production in Suspension Culture on Various Microcarriers
Jerome Jacques
Media Research & Technology, Lonza Walkersville, Inc,
8830 Biggs Ford Road, Walkersville, MD, 21793, USA

Poster #6

Adding insulin to increase influenza virus yield in HEK293 cells for vaccine production
Aziza P. Manceur, Sonia Tremblay, Sven Ansorge
National Research Council Canada, Human Health Therapeutics Portfolio, Vaccine Program, Montreal, Quebec, Canada

Poster #7

Hemocyanins from mollusk as a potent adyuvants/immunostimulants  for vaccines
Alfredo E. De Ioannes 1 and María Inés Becker 1, 2
Biosonda Corporation, Santiago, Chile adeioannes@biosonda.com  
Fundación Ciencia y Tecnología para el Desarrollo (FUCITED), Santiago, Chile

Poster #8

Novel Synthetic vaccines: Immunogenicity of membrane antigens produced with artificial cell membrane technology
Tom Cornell, Fabien Décaillot, Xingfang Su, Madhavan Nallani
ACM Biolabs Pte Ltd, Innovation Centre Blk 2, 18 Nanyang Drive, Singapore 637723, mnallani@acmbiolabs.com

Poster #9

Optimization and qualification of anti-Salmonella Typhi Vi ELISA to assess immunogenicity of Vi conjugate typhoid vaccin es
Mi Seon Jang, Eun Young Lee, Manki Song, Jae Seung Yang

Poster #10

Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformation of the F Glycoprotein
TechnoVax Inc.

Poster #11

Animal Origin-Free and Serum-Free T-cell Media Platform to Support Ex Vivo Expansion and Differentiation of Multiple T-cell Subsets
Pei-Yi Lin, Jackie Pajda, Sarya Mansour, Melanie B. Andolina, Maria Torres-Castillo, Evan R. Zynda, Jennifer L. Donato, Angel M. Varela-Rohena (all from Thermo Fisher Scientific)

Poster #12

Head-to-head comparison of two peripheral blood mononuclear cell (PBMC) isolation methods.
David McIlwain, Samantha Noble, Matthew Nguyen, Julienne Ngaosi, Kevin Noble, Kenneth Kim
WCCT Global, Costa Mesa, California, United States

Poster #13

A Validated Human Volunteer A/California/2009 (H1N1) Influenza Challenge Model
David McIlwain, Bonnie Bock, Melton Affrime, Garry Nolan, Kenneth Kim
WCCT Global, Costa Mesa, California, United States

Poster #14

Mass Cytometry based profiling of host responses to A/California/2009 (H1N1) influenza infection in human volunteers
David McIlwain, Zach Bjornson, Nima Agheepour, Pier Federico Gherardini, Melton Affrime, Bonnie Bock, Kenneth Kim, Garry Nolan
Department of Microbiology and Immunology, Stanford University School of Medicine
WCCT Global, Costa Mesa, California, United States

Poster #15

Seroprevalence of A/California/2009(H1N1) in 2016
Nelson Kim, David McIlwain, Kiersten Piper Tucker, Bonnie Bock, Melton Affrime, Garry Nolan, Kenneth Kim
WCCT Global, Costa Mesa, California, United States

Poster #16

Scale-up Optimization of Vero Cells Cultured on Microcarriers in Serum-free Medium for Vaccine Production
Anna-Barbara Hachmann, Andrew M. Campbell, Stephen F. Gorfien

Poster #17

Economic QBD Production of the Conjugate Vaccine Carrier Protein, CRM197 by a Continuous Manufacturing Process Using Scarab Genomics’ Clean Genome® E. coli
David A Frisch, Cris Blattner, Robert E Novy,  John Brandon, Charles F Landry, Hyunsic Choi, Heather A Kirkpatrick and Frederick R  Blattner

Poster #18

Intranasal Delivery of VitriLife® Live-Attenuated Influenza Vaccine Powder Elicits Robust and Protective Immune Responses in Ferrets
Victor Bronshtein 1 ; S. Mark Tompkins 2 ; Min-Xuan Wang 1 ; Erin A. Miller 1 ; Edward Vonsovich 1 ; Scott K. Johnson 2 ; Cheryl A. Jones 2 ; Jasmina M. Luczo 2 ; David E. Wentworth 3 ; Tatiana Bousse 3 ; Nikolai Petrovsky 4 ; Mark Papania 3
Universal Stabilization Technologies, Inc., San Diego, CA 92121
2 Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602
3 Center for Disease Control and Prevention, Atlanta, GA 30333
4 Vaxine Pty Ltd, Bedford Park, Adelaide, Australia 5042

Poster #19

Stabilization and maintenance of viral vector functionality by means of the amino acid-based formulation technology platform SPS®
Kristina Kemter, Eva Reinauer, Roland Derwand, Martin Scholz

Poster #20

Rapid Vaccine Development & Biomanufacturing Using a Scalable, Non-viral Delivery Platform for Cell Engineering
Dr. James Brady, PhD, VP of Technical Applications & Customer Service Maxcyte

Poster #21

Development of a mutated human parvovirus B19 vaccine to prevent aplastic anemia in congenital and acquired anemias
Shin-je Ghim, PhD; John Trent, PhD; A. B Jenson,MD
James Graham Brown Cancer Center, University of Louisville,  Louisville, KY 40222, USA

Poster #22

Animal Origin-Free and Serum-Free T-cell Media Platform to Support Ex Vivo Expansion and Differentiation of Multiple T-cell Subsets
Pei-Yi Lin, Jackie Pajda, Sarya Mansour, Melanie B. Andolina, Maria Torres-Castillo, Evan R. Zynda, Jennifer L. Donato, Angel M. Varela-Rohena

Poster #23

Production and purification of a virus-like particle (VLP) based Hepatitis C vaccine candidate
Dr Damon Asher, Associate Director, Americas Vaccine Market, Life Science | Process Solutions
MilliporeSigma